ETO Sterilization: A Faster, In-House Alternative at the Same Cost
Updated: Sep 21
A faster, in-house alternative to outsourced ETO sterilization: 50% less validation time, the same cost, and one integrated team.
VOLTAS offers in-house Ethylene Oxide (ETO) sterilization services, giving medical device companies a validated sterilization pathway without relying on outside vendors.
By managing validation and cycle development on-site, VOLTAS reduces sterilization validation timelines by 50% compared to traditional outsourced processes, without increasing the cost to the customer.
ETO Sterilization Under One Roof
ETO sterilization is one of the most common terminal sterilization methods for single-use medical devices, particularly for products that cannot withstand heat or radiation-based methods.
Traditionally, manufacturers have relied on external sterilization providers, requiring products to be shipped off-site, wait for external scheduling, and manage a separate vendor relationship for validation and documentation.
By bringing ETO sterilization in-house, VOLTAS removes another barrier in the development process. Devices can move from cleanroom assembly through sterilization without leaving the facility, maintaining full traceability throughout the process.
Faster Validation. Same Cost. One Team.
VOLTAS’ ISO 13485 compliant facility supports ETO sterilization runs ranging from small development batches to full pallet sterilization, supporting both early-stage builds and ongoing commercial production.
Services include:
In-house ETO sterilization
Sterile barrier packaging and labeling
Full sterilization validation and cycle development
Cleanroom assembly through sterilization under one roof
Complete regulatory documentation and support
With ETO sterilization integrated alongside VOLTAS’ cleanroom assembly, packaging, and regulatory teams, device manufacturers work with one connected team rather than coordinating across multiple vendors.
Ethylene oxide sterilisation remains an important topic for manufacturers handling medical devices that require validated sterilisation processes. Cycle validation, packaging compatibility, and product-specific requirements are essential considerations. These principles are also relevant to the wider discussion around sterile single-use surgical instruments and their preparation for clinical use.